{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:04:15Z","timestamp":1753877055934,"version":"3.41.2"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The incidence of invasive pulmonary aspergillosis (IPA) is rising among intensive care unit (ICU) patients, with early diagnosis and treatment being critical for survival. Lateral flow assays for Aspergillus antigen detection have recently been introduced, enabling rapid results within an hour and potentially supporting earlier clinical decision making and timely antifungal therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective multicenter study included 180 ICU patients, 48 with IPA and 132 controls, across 9 treatment centers. Fungal infections were classified according to the FUNDICU criteria (Invasive Fungal Diseases in Adult Patients in Intensive Care Unit).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among the 180 patients, 48 were classified as having probable IPA, while 132 exhibited host factors and radiologic findings consistent with IPA but did not meet the FUNDICU criteria. In this cohort, the sensitivity and specificity of the bronchoalveolar lavage lateral flow device test for diagnosing probable IPA vs no IPA were 71% (95% CI, 56%\u201383%) and 98% (94%\u2013100%), respectively. The area under the receiver operating characteristic curve was 0.84, indicating good diagnostic performance. The positive and negative likelihood ratios were 31.17 (10.03\u201396.80) and 0.30 (.19\u2013.46), yielding a diagnostic odds ratio of 104 (30\u2013360). The positive and negative predictive values were 92% (78%\u201398%) and 90% (84%\u201395%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Lateral flow device testing may serve as a valuable tool for the rapid diagnosis of IPA in time-critical ICU settings. However, it is not sufficient to definitively rule out the disease, and a comprehensive diagnostic approach remains essential.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofaf256","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T10:46:34Z","timestamp":1745923594000},"source":"Crossref","is-referenced-by-count":0,"title":["Lateral Flow Device <i>Aspergillus<\/i> Routine Testing for Invasive Pulmonary Aspergillosis in Patients Who Are Critically Ill: A Multicenter Intensive Care Unit Cohort Study"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6266-0512","authenticated-orcid":false,"given":"Stefan","family":"Hatzl","sequence":"first","affiliation":[{"name":"Intensive Care Unit, Department of Internal Medicine, Medical University of Graz , Graz ,","place":["Austria"]},{"name":"BioTechMed Graz , Graz ,","place":["Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1977-2196","authenticated-orcid":false,"given":"Lisa","family":"Kriegl","sequence":"additional","affiliation":[{"name":"BioTechMed Graz , Graz ,","place":["Austria"]},{"name":"Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz , Graz ,","place":["Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4918-1749","authenticated-orcid":false,"given":"Christina","family":"Geiger","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz , Graz ,","place":["Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5537-3646","authenticated-orcid":false,"given":"Philipp","family":"Eller","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Department of Internal Medicine, Medical University of Graz , Graz ,","place":["Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6656-3648","authenticated-orcid":false,"given":"Robert","family":"Krause","sequence":"additional","affiliation":[{"name":"BioTechMed Graz , Graz ,","place":["Austria"]},{"name":"Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz , Graz ,","place":["Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"2025052602120321600_ofaf256-B1","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae633","article-title":"Performance of diagnostic algorithms in patients with invasive pulmonary aspergillosis","author":"Hatzl","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025052602120321600_ofaf256-B2","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00134-024-07341-7","article-title":"Invasive fungal diseases in adult patients in intensive care unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM","volume":"50","author":"Bassetti","year":"2024","journal-title":"Intensive Care Med"},{"key":"2025052602120321600_ofaf256-B3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2025052602120321600_ofaf256-B4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13613-021-00827-3","article-title":"New clinical algorithm including fungal biomarkers to better diagnose probable invasive pulmonary aspergillosis in ICU","volume":"11","author":"Hamam","year":"2021","journal-title":"Ann Intensive Care"},{"key":"2025052602120321600_ofaf256-B5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2025052602120321600_ofaf256-B6","doi-asserted-by":"crossref","first-page":"106159","DOI":"10.1016\/j.jinf.2024.106159","article-title":"Performance of the galactomannan test for the diagnosis of invasive pulmonary aspergillosis using non-invasive proximal airway samples","volume":"88","author":"Chun","year":"2024","journal-title":"J Infect"},{"key":"2025052602120321600_ofaf256-B7","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1186\/s13054-020-03367-7","article-title":"Point of care Aspergillus testing in intensive care patients","volume":"24","author":"Mercier","year":"2020","journal-title":"Crit Care"},{"key":"2025052602120321600_ofaf256-B8","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00134-021-06431-0","article-title":"Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial","volume":"47","author":"Vanderbeke","year":"2021","journal-title":"Intensive Care Med"},{"key":"2025052602120321600_ofaf256-B9","doi-asserted-by":"crossref","first-page":"e43347","DOI":"10.1371\/journal.pone.0043347","article-title":"Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis","volume":"7","author":"Zou","year":"2012","journal-title":"PLoS One"},{"key":"2025052602120321600_ofaf256-B10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13054-015-0905-x","article-title":"Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients","volume":"19","author":"Eigl","year":"2015","journal-title":"Crit Care"},{"key":"2025052602120321600_ofaf256-B11","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025052602120321600_ofaf256-B12","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1128\/CVI.00068-08","article-title":"Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis","volume":"15","author":"Thornton","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"2025052602120321600_ofaf256-B13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/JCM.02142-12","article-title":"Interlaboratory and interstudy reproducibility of a novel lateral-flow device and influence of antifungal therapy on detection of invasive pulmonary aspergillosis","volume":"51","author":"Wiederhold","year":"2013","journal-title":"J Clin Microbiol"},{"key":"2025052602120321600_ofaf256-B14","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2025052602120321600_ofaf256-B15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13054-021-03753-9","article-title":"Antifungal prophylaxis for prevention of COVID-19\u2013associated pulmonary aspergillosis in critically ill patients: an observational study","volume":"25","author":"Hatzl","year":"2021","journal-title":"Critical Care"},{"key":"2025052602120321600_ofaf256-B16","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1093\/cid\/ciaa1786","article-title":"Defining galactomannan positivity in the updated EORTC\/MSGERC consensus definitions of invasive fungal diseases","volume":"72","author":"Mercier","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025052602120321600_ofaf256-B17","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/429921","article-title":"Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay","volume":"40","author":"Marr","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2025052602120321600_ofaf256-B18","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1128\/JCM.06513-11","article-title":"Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis","volume":"50","author":"Chai","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2025052602120321600_ofaf256-B19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s12281-020-00409-z","article-title":"The Aspergillus lateral flow assay for the diagnosis of invasive aspergillosis: an update","volume":"14","author":"Jenks","year":"2020","journal-title":"Curr Fungal Infect Rep"},{"key":"2025052602120321600_ofaf256-B20","doi-asserted-by":"crossref","first-page":"e1737","DOI":"10.1093\/cid\/ciaa1281","article-title":"Performance of the bronchoalveolar lavage fluid Aspergillus galactomannan lateral flow assay with cube reader for diagnosis of invasive pulmonary aspergillosis: a multicenter cohort study","volume":"73","author":"Jenks","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025052602120321600_ofaf256-B21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00134-024-07767-z","article-title":"A multivariable prediction model for invasive pulmonary aspergillosis in immunocompromised patients with acute respiratory failure (IPA-GRRR-OH score)","volume":"51","author":"Friol","year":"2025","journal-title":"Intensive Care Med"},{"key":"2025052602120321600_ofaf256-B22","doi-asserted-by":"crossref","DOI":"10.1007\/s00134-025-07838-9","article-title":"Validation of the \u201cinvasive pulmonary aspergillosis in immunocompromised patients with acute respiratory failure score\u201d (IPA-GRRR-OH score)","author":"Hatzl","year":"2025","journal-title":"Intensive Care Med"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf256\/63026652\/ofaf256.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/5\/ofaf256\/63026652\/ofaf256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/5\/ofaf256\/63026652\/ofaf256.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T06:12:21Z","timestamp":1748239941000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf256\/8121664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,4,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf256","relation":{},"ISSN":["2328-8957"],"issn-type":[{"type":"electronic","value":"2328-8957"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,4,28]]},"article-number":"ofaf256"}}